Skip to content
AwardedSVNGoods€206,700

REAGENTI ZA PRESEJANJE/DETEKCIJO UROTELNEGA KARCINOMA, IZRAŽANJE BCR::ABL1 IN NPM1

Published
Published 16 June 2025
Deadline
Closed 22 July 2025

Overview

Univerzitetni klinični center Maribor procured reagents for screening and detection of urothelial carcinoma, BCR::ABL1 expression, and NPM1 expression. The contract was awarded to BIOMEDIS M.B. trgovina d.o.o. for 156,487.80 EUR in September 2025.

Key details

Country
SVN
Status
Awarded
Category
Goods
Estimated value
€206,700
Procedure
Open
SME suitable
Yes
Published
16 June 2025
Deadline
Closed
Classification (CPV)
Medical consumables

Award outcome

Awarded value
€156,488
Award date
4 September 2025
Contract period
— → 14 August 2029
Winner
  • BIOMEDIS M.B. trgovina d.o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    22 September 2025

  2. Contract Notice

    11 July 2025

  3. Contract Notice

    16 June 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: REAGENTI ZA PRESEJANJE/DETEKCIJO UROTELNEGA KARCINOMA, IZRAŽANJE BCR::ABL1 IN NPM1 — won by BIOMEDIS M.B. trgovina d.o.o. — Skim